Gallant Therapeutics
                                                                                                                                    
                                                                                                United States
                                                 -                                                 SAN DIEGO, CA
                                                                                            
                                                                                    - 09/01/2024
 - Series A
 - $15,000,000
 
Gallant Therapeutics is a clinical-stage animal health biotechnology company setting a new standard in animal health by harnessing the power of stem cell therapy to treat the root cause of diseases in dogs and cats. Our pipeline of off-the-shelf mesenchymal stem cell (MSC) therapies has the potential to treat a broad range of diseases, including canine and feline osteoarthritis (OA), feline chronic kidney disease (CKD), and others. The first product based on our uterine-derived platform for feline chronic gingivostomatitis (FCGS), is on track for conditional approval by the FDA in 2025. United by a love of and commitment to animals, Gallant’s team includes industry pioneers in veterinary regenerative medicine with deep experience in cell therapy product development, manufacturing and commercialization.
- Industry Biotechnology Research
 - Website https://www.gallanttherapeutics.com/
 - LinkedIn https://www.linkedin.com/company/gallanttherapeutics/about/
 
Related People
Linda BlackFounder
                                                    
                                                                                                                United States -
                                                         San Diego County, California
                                                    
                                                On the day my childhood horse almost died, I decided to become a veterinarian. As I grew as a professional, I uncovered my love for science and research and, ultimately, regenerative medicine. 
Along the way, I learned a lot about leadership, what makes a good team, how to care for them, and how to inspire people to reach for something far bigger than themselves. 
Today, I use these learnings to lead a team of pioneers in a field that we believe will transform animal health. 
Professionally, I excel at:
- Creating a values-based culture
- Compassionate leadership
- Putting people at the center of all that I do
- Innovative science 
- Being calm in a crisis
- Accountability- the buck stops with me
Personally, I am:
- Passionate about personal development
- Writing obsessed 
- A fitness/well-being fanatic
- A mom before all…
I love the fact that I work with incredible people on a mission to create a new class of therapies for our pets that treat the root cause of disease and have the potential to alter their quality of life and, therefore ours ❤️ 
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                mimic(SWITZERLAND) |  $160,000,000  | (Nov 4, 2025)
                            
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                    
                                    
                                    
                                    
                                    
                                    
                                    
                                    
                                    
                                    
                                    
                                            
                                                
                                                    
                                                    
                                                
                                                    
                                                
                                                
                                                    
                                                
                                                
                                                
                                                
                                                
                                                    
                                                
                                                    
                                                                        
                                Zeeg |  $1,265,935  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)
                                                                        
                                octonomy |  $20,000,000  | (Nov 4, 2025)
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                Hullbot |  $16,000,000  | (Nov 4, 2025)
                            
                                                                        
                                Indomo |  $25,000,000  | (Nov 4, 2025)
                                                                        
                                AUI™ (Augmented Intelligence) |  $20,000,000  | (Nov 4, 2025)
                                                                        
                                Popai Health |  $11,000,000  | (Nov 4, 2025)